Philippe, Geneviève ; Université de Liège - ULiège > Département de pharmacie > Pratiques officinales et soins pharmaceutiques
Louis, Renaud ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Schleich, Florence ; Université de Liège - ULiège > Département des Sciences de l'activité physique et de la réadaptation > Physiologie humaine et physiologie de l'effort physique
Language :
English
Title :
What drives rescue bronchodilators overuse in asthmatics? Demographic features, low FEV1 and high sputum eosinophil counts
Noorduyn SG, Qian C, Johnston KM, et al. SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada). ERJ Open Res 2022; 8: 00140-2022.
Nwaru BI, Ekström M, Hasvold P, et al. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J 2020; 55: 1901872.
Schleich FN, Chevremont A, Paulus V, et al. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur Respir J 2014; 44: 97–108.
Juniper EF, O'Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902–907.
Bel EH, Zwinderman AH, Timmers MC, et al. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. Thorax 1991; 46: 9–14.
Patel M, Pilcher J, Reddel HK, et al. Metrics of salbutamol use as predictors of future adverse outcomes in asthma. Clin Exp Allergy 2013; 43: 1144–1151.
O'Byrne PM, Parameswaran K. Pharmacological management of mild or moderate persistent asthma. Lancet 2006; 368: 794–803.
Schatz M, Zeiger RS, Yang SJ, et al. Prospective study on the relationship of obesity to asthma impairment and risk. J Allergy Clin Immunol Pract 2015; 3: 560–565.e1.
Chaudhuri R, McSharry C, McCoard A, et al. Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy 2008; 63: 132–135.
Louis G, Pétré B, Sousa-Pinto B, et al. When patient-reported respiratory symptoms shed light on pathophysiology in adult asthma: a cross-sectional study. Sci Rep 2024; 14: 29997.
Holmes J, McGarvey LPA, Birring SS, et al. An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma. Eur Respir J 2022; 60: 2103205.
Schleich FN, Seidel L, Sele J, et al. Exhaled nitric oxide thresholds associated with a sputum eosinophil count ⩾3% in a cohort of unselected patients with asthma. Thorax 2010; 65: 1039–1044.
Verleden GM, Dupont LJ, Verpeut AC, et al. The effect of cigarette smoking on exhaled nitric oxide in mild steroid-naive asthmatics. Chest 1999; 116: 59–64.
Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999; 160: 594–599.
Gamble J, Stevenson M, McClean E, et al. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med 2009; 180: 817–822.
Toh MR, Ng GXZ, Goel I, et al. Asthma prescribing trends, inhaler adherence and outcomes: a Real-World Data analysis of a multi-ethnic Asian asthma population. NPJ Prim Care Respir Med 2024; 34: 1.
